Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nasdaq100 ETF (QQQ) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Nasdaq100 ETFTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Nasdaq100 ETF vs uniQure N.V. Ordinary Shares — how do they compare? Nasdaq100 ETF trades at $721.28 (market cap $501.32B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Nasdaq100 ETF is far larger — about 338.7× uniQure N.V. Ordinary Shares's market cap, and Nasdaq100 ETF is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nasdaq100 ETF for 163 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

QQQQURE
Market Cap
$501.32B$1.48B
Volume
28,524,9182,488,780
52-Week High
$759.66$70.59
52-Week Low
$558.34$9.03
Typical Hold Time
163 Days0 Days
Sector
—Health
Enterprise Value
—$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nasdaq100 ETF

QQQ trades at $728.95, down 2.28% today amid broader market pressure. Technical indicators show a bullish trend with moving averages supporting upside momentum, while oscillators remain neutral. The ETF faces mixed analyst sentiment with a 50/50 split between buy and sell recommendations. Recent news highlights concerns about AI market sustainability and Fed rate impacts, though historical patterns suggest potential post-midterm election strength.

QQQ's concentrated tech exposure offers growth potential through AI-driven innovation but carries valuation risks amid elevated market levels. Key risks include interest rate sensitivity and sector concentration, while institutional expansion through new international ETFs signals long-term confidence in the innovation theme.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QQQ
68% Buy32% Sell
Avg holding period · 163 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

Read more on QQQ →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →